GAM
GBT

Griffin Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Griffin Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-365
Closed -$19K – 502
2019
Q2 		$19K Buy
+365
New +$21K ﹤0.01% 433

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Griffin Asset Management's GBT Position: Q3 2019 in Review

Griffin Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 365 shares — an estimated $19K sold.

Griffin Asset Management first reported a position in GBT in Q2 2019 and held it in 1 quarter. The position peaked at $19K in Q2 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Griffin Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Griffin Asset Management sold 365 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $19K.
  • Griffin Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Griffin Asset Management's Global Blood Therapeutics, Inc. position peaked at $19K in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Griffin Asset Management's 13F filing for Q3 2019, filed 5 Nov 2019.